Results from First Clinical Study Using Danoprevir to Treat Naive and Experienced COVID-19 Patients
- Wednesday, March 25, 2020, 7:01
- Finance
- Add a comment
HANGZHOU and SHAOXING, China, March 24, 2020 /PRNewswire/ — Ascletis Pharma Inc. (HKEX code: 1672) announces today the first clinical study using Ganovo®(danoprevir) to treat naive and experienced COVID-19 patients was published in medRxiv. The data from this small-sample clinical study…
About the Author
adminasapcorp has written 41816 stories on this site.